Statistics for Puma Biotechnology (id:8313 PBYI)
Valuation metrics
Market cap
134.50M
Enterprise value
108.44M
Trailing P/E (ttm)
5.83
Forward P/E
11.42
PEG ratio
11.42
Price/Sales (ttm)
0.55
Price/Book (mrq)
1.89
Enterprise Value/Revenue
0.44
Enterprise Value/EBITDA
2.43
Overview
Shares outstanding
49.09M
Float
32.51M
Shares short
3.19M
% Held by insiders
0.15%
% Held by institutions
0.68%
Average volume (10 days)
848.37K
Average volume (90 days)
Price summary
52-Week low
2.23
52-Week high
7.73
52-Week change
-49.67%
Beta
1.08
50-Day moving average
2.73
200-Day moving average
3.94
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
9.54%
Operating margin
27.41%
Operational effectiveness
Return on assets
9.73%
Return on equity
42.32%
Income statement
Revenue (ttm)
5.04
Revenue per share (ttm)
5.04
Quarterly revenue growth (yoy)
2.50
Gross profit (ttm)
172.96M
EBITDA
49.42M
Net income to common (ttm)
23.24M
Diluted EPS (ttm)
0.47
Quarterly earnings growth (yoy)
250.50%
Balance sheet
Total cash (mrq)
96.72M
Total cash per share (mrq)
1.97
Total debt (mrq)
86.37M
Total Debt/Equity (mrq)
121.50
Current ratio (mrq)
142.00%
Book value per share (mrq)
1.45
Cash flow
Cash flow statement
33.77M
Levered free cash flow (LFCF)
32.70M